Thomasville National Bank Slashes Zimmer Biomet Stake by 92.9% Despite Earnings Beat

Thomasville National Bank has executed a major divestment from Zimmer Biomet Holdings (ZBH), selling 102,815 shares and reducing its position by 92.9%. This significant institutional sell-off occurred despite the company surpassing quarterly earnings and revenue estimates. Zimmer Biomet also declared a quarterly dividend of $0.24, signaling continued commitment to shareholder returns. Analysts currently maintain a consensus 'Hold' rating on the stock, with an average price target of $105.95. While the bank's exit represents a substantial shift in institutional ownership, the company's strong financial performance provides a necessary counter-balance. Consequently, the market outlook remains neutral as investors weigh the institutional exit against solid fundamental growth in the medical devices sector.